Historical record - last NADAC effective date: 10/17/2018
Product Information
AMLODIPINE-BENAZEPRIL 2.5-10 is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1687 per EA under NDC 65862058205. Its NADAC has been published 256 times since Dec 5, 2013.
FDA first approved this application on Sep 5, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5; 10 mg/1; mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862058205
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
10/17/2018
Active Ingredients
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202239FDA Approved
9/5/2012
TE Code
AB
On Market Since
9/5/2012
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-BENAZEPRIL 2.5-10 has been published 256 times since Dec 5, 2013, and over the history we have for it it has declined 75.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1687 per EA |
|---|---|
| All-time high | $0.6878 (May 14, 2014) |
| All-time low | $0.1442 (Sep 20, 2017) |
| Median price | $0.5386 |
| Average price | $0.4580 |
| Largest weekly change | +58.1% (Sep 19, 2018) |
| Weeks tracked | 256 |
| Tracking since | Dec 5, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-75.2%
Last surveyed Oct 24, 2018 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 43% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Amlodipine and Benazepril Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin Converting Enzyme Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AMLODIPINE-BENAZEPRIL 2.5-10?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-BENAZEPRIL 2.5-10, manufactured by Aurobindo Pharma Limited, is $0.1687 per EA (NDC 65862058205), effective Oct 24, 2018.
How has the price of AMLODIPINE-BENAZEPRIL 2.5-10 changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-BENAZEPRIL 2.5-10 has declined 75.2%. It has been tracked across 256 weekly CMS publications since Dec 5, 2013.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-BENAZEPRIL 2.5-10?
Since Dec 5, 2013, the NADAC for AMLODIPINE-BENAZEPRIL 2.5-10 has ranged from a low of $0.1442 (Sep 20, 2017) to a high of $0.6878 (May 14, 2014), with a median of $0.5386 per EA.
Are there cheaper alternatives to AMLODIPINE-BENAZEPRIL 2.5-10?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AMLODIPINE-BENAZEPRIL 2.5-10, is $0.0956 per EA — about 43% below AMLODIPINE-BENAZEPRIL 2.5-10.
Who manufactures AMLODIPINE-BENAZEPRIL 2.5-10?
AMLODIPINE-BENAZEPRIL 2.5-10 (NDC 65862058205) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.